One of the promising regimens effective against some tumor cells including NBL use DNA-damaging cytostatics such as doxorubicin, etoposide, or cisplatin in combination with several HDAC inhibitors (for a review see [15,20,22,23,24,25,26,27,28,56]). Here, HDAC9 is linked to neoplasm.